Literature DB >> 11026697

Efficacy of conventional radiotherapy for recurrent meningioma.

M Kokubo1, Y Shibamoto, J A Takahashi, K Sasai, N Oya, N Hashimoto, M Hiraoka.   

Abstract

Results of radiation therapy for 20 patients with recurrent meningioma were analyzed. The patients included 8 men and 12 women, with a median age of 55 years. All of the patients had undergone at least one operation prior to the reoperation preceding radiotherapy. Ten patients had benign meningiomas, while 4 and 6 patients had atypical and malignant meningiomas, respectively, at the time of radiotherapy. The median radiation dose was 59.4 Gy (range: 50-61.2 Gy). The local control rate at 5 years was 36% for all 20 patients (41% for benign meningiomas and 30% for atypical or malignant meningiomas). The 5-year survival rate was 47%. Excluding 2 patients whose follow-up period was shorter than the preradiotherapy interval from the previous operation, the postradiation recurrence-free period was longer than the preradiotherapy interval in 50% (9/18) of the patients. No serious complications of radiotherapy were observed. Radiotherapy seemed to be effective in controlling the tumor or delaying recurrence in at least half of the patients. However, higher doses of radiation, using sophisticated radiation techniques, may be necessary to obtain higher control rates.

Entities:  

Mesh:

Year:  2000        PMID: 11026697     DOI: 10.1023/a:1006430102406

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  Fractionated external-beam radiation therapy for meningiomas of the cavernous sinus.

Authors:  P D Maguire; R Clough; A H Friedman; E C Halperin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-04-01       Impact factor: 7.038

2.  Long-term outcomes after meningioma radiosurgery: physician and patient perspectives.

Authors:  D Kondziolka; E I Levy; A Niranjan; J C Flickinger; L D Lunsford
Journal:  J Neurosurg       Date:  1999-07       Impact factor: 5.115

3.  Stereotactically guided conformal radiotherapy for meningiomas.

Authors:  H Alheit; F H Saran; A P Warrington; I Rosenberg; J Perks; R Jalali; S Shepherd; C Beardmore; B Baumert; M Brada
Journal:  Radiother Oncol       Date:  1999-02       Impact factor: 6.280

Review 4.  Meningiomas.

Authors:  P M Black
Journal:  Neurosurgery       Date:  1993-04       Impact factor: 4.654

5.  Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases.

Authors:  R C Chan; G B Thompson
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

6.  The role of radiation therapy in the management of intracranial meningiomas.

Authors:  M J Solan; S Kramer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-04       Impact factor: 7.038

Review 7.  Radiotherapy for atypical or malignant intracranial meningioma.

Authors:  M F Milosevic; P J Frost; N J Laperriere; C S Wong; W J Simpson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-03-01       Impact factor: 7.038

8.  Fractionated radiation therapy in the treatment of intracranial meningiomas: local control, functional efficacy, and tolerance in 91 patients.

Authors:  J P Maire; M Caudry; J Guérin; D Célérier; F San Galli; N Causse; R Trouette; M Dautheribes
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-09-30       Impact factor: 7.038

9.  Radiation therapy in the treatment of meningioma: the Joint Center for Radiation Therapy experience 1970 to 1982.

Authors:  A R Forbes; I D Goldberg
Journal:  J Clin Oncol       Date:  1984-10       Impact factor: 44.544

10.  Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay.

Authors:  Y Shibamoto; T Shibata; S Miyatake; Y Oda; T Manabe; G Ohshio; K Yagi; C Streffer; M Takahashi; M Abe
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

View more
  10 in total

Review 1.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

2.  Sellar meningiomas: an endocrinologic perspective.

Authors:  Matheni Sathananthan; Airani Sathananthan; Bernd W Scheithauer; Caterina Giannini; Fredric B Meyer; John L D Atkinson; Dana Erickson
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

3.  Role of external beam radiotherapy in the treatment of relapsing meningioma.

Authors:  M Buglione; B De Bari; F Trevisan; P Ghirardelli; S Pedretti; L Triggiani; S M Magrini
Journal:  Med Oncol       Date:  2014-02-07       Impact factor: 3.064

4.  Definitive embolization of meningiomas. A review.

Authors:  B T Bateman; E Lin; J Pile-Spellman
Journal:  Interv Neuroradiol       Date:  2005-10-25       Impact factor: 1.610

5.  Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.

Authors:  Reshu Gupta; Venkateswara Rao Gogineni; Arun Kumar Nalla; Chandramu Chetty; Jeffrey D Klopfenstein; Andrew J Tsung; Sanjeeva Mohanam; Jasti S Rao
Journal:  Int J Oncol       Date:  2011-02-02       Impact factor: 5.650

6.  Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients.

Authors:  David van Nieuwenhuizen; Martin Klein; Lukas J A Stalpers; Sieger Leenstra; Jan J Heimans; Jaap C Reijneveld
Journal:  J Neurooncol       Date:  2007-04-13       Impact factor: 4.130

7.  Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.

Authors:  Muhammad O Chohan; Christopher T Ryan; Ranjodh Singh; Ryan M Lanning; Anne S Reiner; Marc K Rosenblum; Viviane Tabar; Philip H Gutin
Journal:  Neurosurgery       Date:  2018-06-01       Impact factor: 4.654

8.  Effect of breathing a hyperoxic hypercapnic gas mixture on the oxygenation of meningiomas; preliminary results.

Authors:  Janneke Schuuring; Mark Rijpkema; Hans Bernsen; Pieter Bernsen; Richard van der Maazen; Johannes Kaanders; Albert van der Kogel; Arend Heerschap
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

9.  RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells.

Authors:  Venkateswara Rao Gogineni; Odysseas Kargiotis; Jeffrey D Klopfenstein; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2009-01       Impact factor: 5.650

10.  Systematic Analysis of Outcomes for Surgical Resection and Radiotherapy in Patients with Papillary Meningioma.

Authors:  Christina Fong; Daniel T Nagasawa; Lawrance K Chung; Brittany Voth; Nicole Cremer; Kimberly Thill; Nolan Ung; Quinton Gopen; Isaac Yang
Journal:  J Neurol Surg B Skull Base       Date:  2015-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.